Clínicas del dolor y cuidados paliativos en México: manejo del estreñimiento inducido por opiáceos. Conclusiones de un grupo de expertos

• Autores: José Alberto Flores Cantisani, Argelia Lara Solares, M. López, G. Aréchiga, D. Morgenstern Kaplan
• Localización: Revista de la Sociedad Española del Dolor (SED), ISSN 1134-8046, Vol. 16, Nº. 8, 2009, págs. 468-481
• Idioma: español
• DOI: 10.1016/s1134-8046(09)73102-7
• Títulos paralelos:
  • Pain clinics and palliative care in Mexico: management of opioid-induced constipation. Conclusions of an expert group
• Enlaces
  • Texto completo (pdf)
• Resumen
  • español

    A finales de septiembre de 2008, 15 líderes de opinión en el tratamiento del dolor y los cuidados paliativos de México se reunieron en la ciudad de México con el objetivo de elaborar una guía clínica acerca del uso de opiáceos y sus efectos secundarios, con especial acento en el estreñimiento, y se propuso un nuevo esquema de tratamiento. Los participantes trabajan actualmente en unidades de dolor o de paliativos por todo México y algunos son participante activos en la elaboración de medidas reguladoras sobre el uso de opiáceos. Durante la elaboración de esta guía, se ha publicado la Ley de Reforma del Tratamiento Paliativo de México, que ha entrado en vigor el 6 de enero de 2009.

  • English

    At the end of September 2008, 15 leading figures in pain treatment and palliative care in Mexico met in Mexico City to design a clinical guideline on the use of opioids and the secondary effects of these drugs, with special emphasis on constipation. A new treatment scheme was proposed. The participants currently work in pain or palliative care units throughout Mexico and some are active participants in the design of regulatory measures on opioid use. During the drafting of this guideline, the law reforming palliative treatment in Mexico was passed and came into effect on 6th January, 2009.

• Referencias bibliográficas
  • Portenoy, R. (1989). Mechanisms of clinical pain observations and speculations. Neurol Clin North Am.. 7. 205
  • Bruera, E, Kim, HN. (2003). Cancer pain. JAMA.. 290. 2476
  • Woolf, C, Bennet, G, Doherty, M. (1998). Towards a mechanism based classification of pain. Pain.. 77. 227
  • Parkin, M. (2001). Global cancer statistics in the year 2000. The Lancet Oncology. 2. 533
  • (2005).
  • Fisch, M, Burton, A. (2007). Cancer Pain Management. McGraw-Hill. New York.
  • Bruera, E, Schoeller, T, Wenk, R, MacEachern, T, Marcelino, S, Hanson, J. (1995). A prospective multicenter assessment of the Edmonton staging...
  • Foley, KM. (2001). Cancer principles and practice of oncology. 6. Lippincott Williams & Wilkins. Philadelphia.
  • (1990). Cancer pain relief and pailiative care. WHO. Geneva.
  • Torres, LM, Calderón, E, Pernía, A, Martínez Vázquez, J, Micó, JA. (2002). De la escalera al ascensor. Rev Soc Esp Dolor.. 9. 289
  • Sanz, J, Gómez, BX, Gómez, SM, Núñez, OJ. (1993). SECPAL.
  • Elsayem, A, Swint, K, Fisch, M. (2004). Palliative care inpatient service in a comprehensive cancer center. J Clin Oncol.. 22. 2008
  • Twycross, R, Wilcock, A. (2001). Symptom management in advanced cancer. Oxford University Press. Oxford.
  • Twycross, R. (2001). Pain relief in advanced cancer. Oxford University Press. Oxford.
  • Benyamin, R, Trescot, AM, Datta, S, Buenaventura, R, Adlaka, R, Sehgal, N. (2008). Opioid complications and side effects. Pain Physician....
  • Trescot, AM, Datta, S, Lee, M, Hansen, H. (2008). Opioid pharmacology. Pain Physician. 11. 133
  • Smith, HS. (2008). Peripherally-acting opioids. Pain Physician. 11. 121
  • DeHaven-Hudkins, DL, DeHaven, RN, Little, PJ, Techner, LM. (2008). The involvement of the µ-opioid receptor in gastrointestinal patho-physiology:...
  • Harris, MS. (1998). Practical Gastroenterology. 22. 12
  • (2002). J Clin Gastroenterol.. 34. 27-33
  • Bruera, E, Suárez-Almazor, M, Velasco, A, Bertolino, M, Macdonald, S, Hanson, J. (1994). The assessment of constipation in terminal cancer...
  • Choi, YS, Billings, JA. (2002). Opioid antagonist: a review of their role in palliative care, focusing on use in opioid-related constipation....
  • Clemensa, KE. (2008). Management of constipation in palliative care patients. Current Opinion in Supportive and Palliative Care. 2. 22
  • Karam, SE, Nies, DM. (1994). Student/staff collaboration: a pilot bowel management program. J Gerontol Nurs.. 20. 32-40
  • Levy, MH. (2000). Development of a protocol to prevent opioid-induced constipation in patients with cancer: a research utilization project....
  • Clifford, G. (2007). Update on the management of opioid-induced constipation. Topics in Pain Management. 23. 11
  • Yuan, CS, Foss, JF. (2000). Methylnaltrexone: investigation of clinical applications. Drug Dev Res.. 50. 133
  • Portenoy, RK, Thomas, J, Moehl Boatwright, ML, Tran, D, Galasso, FL, Stambler, N. (2008). Subcutaneous methylnaltrexone for the treatment...
  • Slatkin, N, Thomas, J, Lipman, AG, Wilson, G, Boatwright, ML, Wellman, C. (2009). Methylnaltrexone for treatment of opioid induced constipation...
  • Thomas, J, Karver, S, Cooney, GA, Chamberlain, BH, Watt, CK, Slatkin, NE. (2008). Methylnaltrexone for opioid-induced constipation in advance...